The Research & Development Council of New Jersey (“Council”) is proud to honor 15 winning organizations with the 2018 Edison Patent Award. These winners, along with 61 inventors, were recognized at the 39th Edison Patent Awards Ceremony & Reception at the Liberty Science Center in Jersey City.
BASF, Celularity, Ethicon, part of Johnson & Johnson Medical Device Companies, ExxonMobil, Honeywell, Johnson & Johnson Consumer Inc., Merck, NJIT, Princeton University, Rutgers Biomedical and Health Sciences, Rutgers University-New Brunswick, Siemens Corporate Technology, Siemens Healthineers, Stevens Institute of Technology and SubCom, were recognized for innovative patent work spanning 15 R&D categories, including: agriculture, biomaterials, biotechnology, consumer, enabling technologies, energy, environmental, industrial processes, information technology, medical imaging, pharmaceutical, public health, smart grid, technology transfer, and telecommunications.
Celularity and inventors Mohit Bhatia, Chris Lugo, Qian Ye, and James W. Edinger won in the Biotechnology category for the patent "Human Placental Collagen Compositions, and Methods of Making and Using the Same (U.S. Patent 9,974,840).
